{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:12:30Z","timestamp":1771855950466,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40268-020-00317-0","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T07:02:32Z","timestamp":1596610952000},"page":"267-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7939-5524","authenticated-orcid":false,"given":"Marija","family":"Pesic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Ossig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Borkett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Donsbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van-Anh","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"3","key":"317_CR1","doi-asserted-by":"publisher","first-page":"UE01","DOI":"10.7860\/JCDR\/2018\/30823.11263","volume":"12","author":"S Bansal","year":"2018","unstructured":"Bansal S, Singhal S. Remimazolam (CNS7056): an Emerging Sedative and General Anaesthetic. J Clin Diagn Res. 2018;12(3):UE01-03. https:\/\/doi.org\/10.7860\/JCDR\/2018\/30823.11263.","journal-title":"J Clin Diagn Res"},{"issue":"Suppl 1","key":"317_CR2","doi-asserted-by":"publisher","first-page":"61S","DOI":"10.1111\/j.1365-2125.1979.tb04667.x","volume":"7","author":"JR Wittenborn","year":"1979","unstructured":"Wittenborn JR. Effects of benzodiazepines on psychomotor performance. Br J Clin Pharmacol. 1979;7(Suppl 1):61S\u20137S. https:\/\/doi.org\/10.1111\/j.1365-2125.1979.tb04667.x.","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"317_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.15288\/jsa.2003.64.756","volume":"64","author":"M Testa","year":"2003","unstructured":"Testa M, Livingston JA, Vanzile-Tamsen C, Frone MR. The role of women\u2019s substance use in vulnerability to forcible and incapacitated rape. J Stud Alcohol. 2003;64(6):756\u201364. https:\/\/doi.org\/10.15288\/jsa.2003.64.756.","journal-title":"J Stud Alcohol"},{"key":"317_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jflm.2018.11.006","volume":"61","author":"TR Fiorentin","year":"2019","unstructured":"Fiorentin TR, Logan BK. Toxicological findings in 1000 cases of suspected drug facilitated sexual assault in the United States. J Forensic Leg Med. 2019;61:56\u201364. https:\/\/doi.org\/10.1016\/j.jflm.2018.11.006.","journal-title":"J Forensic Leg Med"},{"issue":"5","key":"317_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1503\/cmaj.080570","volume":"180","author":"J Du Mont","year":"2009","unstructured":"Du Mont J, Macdonald S, Rotbard N, Asllani E, Bainbridge D, Cohen MM. Factors associated with suspected drug-facilitated sexual assault. CMAJ. 2009;180(5):513\u20139. https:\/\/doi.org\/10.1503\/cmaj.080570.","journal-title":"CMAJ"},{"key":"317_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.forsciint.2018.08.034","volume":"292","author":"A Grela","year":"2018","unstructured":"Grela A, Gautam L, Cole MD. A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases. Forensic Sci Int. 2018;292:50\u201360. https:\/\/doi.org\/10.1016\/j.forsciint.2018.08.034.","journal-title":"Forensic Sci Int"},{"issue":"11","key":"317_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, et al. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27(11):967\u201371. https:\/\/doi.org\/10.1177\/0269881113503509.","journal-title":"J Psychopharmacol"},{"issue":"Suppl 2","key":"317_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000137919","volume":"27","author":"T Seppala","year":"1983","unstructured":"Seppala T, Nuotto E, Dreyfus JF. Drug\u2013alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Pharmacology. 1983;27(Suppl 2):127\u201335. https:\/\/doi.org\/10.1159\/000137919.","journal-title":"Pharmacology"},{"issue":"5","key":"317_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.1998.00175.x","volume":"23","author":"E Tanaka","year":"1998","unstructured":"Tanaka E, Misawa S. Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants\u2014an update. J Clin Pharm Ther. 1998;23(5):331\u20136.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"317_CR10","first-page":"214","volume":"13","author":"CE Griffin 3rd","year":"2013","unstructured":"Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214\u201323.","journal-title":"Ochsner J"},{"issue":"137","key":"317_CR11","first-page":"43","volume":"29","author":"A Leary","year":"1999","unstructured":"Leary A, MacDonald T. Interactions between alcohol and drugs. Proc R Coll Physicians Edinb. 1999;29(137):43.","journal-title":"Proc R Coll Physicians Edinb"},{"issue":"6","key":"317_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40262-014-0226-2","volume":"54","author":"RB Parker","year":"2015","unstructured":"Parker RB, Hu ZY, Meibohm B, Laizure SC. Effects of alcohol on human carboxylesterase drug metabolism. Clin Pharmacokinet. 2015;54(6):627\u201338. https:\/\/doi.org\/10.1007\/s40262-014-0226-2.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"317_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274\u201383. https:\/\/doi.org\/10.1213\/ANE.0b013e31823f0c28.","journal-title":"Anesth Analg."},{"issue":"2","key":"317_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00177553","volume":"96","author":"JM Rusted","year":"1988","unstructured":"Rusted JM, Warburton DM. The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology. 1988;96(2):145\u201352.","journal-title":"Psychopharmacology"},{"issue":"Pt 3","key":"317_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/brain\/111.3.695","volume":"111","author":"BJ Sahakian","year":"1988","unstructured":"Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson\u2019s disease. Brain. 1988;111(Pt 3):695\u2013718. https:\/\/doi.org\/10.1093\/brain\/111.3.695.","journal-title":"Brain"},{"issue":"Suppl 1","key":"317_CR16","doi-asserted-by":"publisher","first-page":"43S","DOI":"10.1111\/j.1365-2125.1983.tb02270.x","volume":"16","author":"P Heizmann","year":"1983","unstructured":"Heizmann P, Eckert M, Ziegler WH. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol. 1983;16(Suppl 1):43S\u20139S. https:\/\/doi.org\/10.1111\/j.1365-2125.1983.tb02270.x.","journal-title":"Br J Clin Pharmacol."},{"issue":"12","key":"317_CR17","first-page":"2383","volume":"27","author":"JP Cano","year":"1977","unstructured":"Cano JP, Soliva M, Hartmann D, Ziegler WH, Amrein R. Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung. 1977;27(12):2383\u20138.","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"317_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1213\/00000539-198301000-00001","volume":"62","author":"M Divoll","year":"1983","unstructured":"Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg. 1983;62(1):1\u20138.","journal-title":"Anesth Analg"},{"issue":"1","key":"317_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jps.2600680119","volume":"68","author":"DJ Greenblatt","year":"1979","unstructured":"Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci. 1979;68(1):57\u201363. https:\/\/doi.org\/10.1002\/jps.2600680119.","journal-title":"J Pharm Sci"},{"issue":"1","key":"317_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.110.002717","volume":"63","author":"TI Saari","year":"2011","unstructured":"Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev. 2011;63(1):243\u201367. https:\/\/doi.org\/10.1124\/pr.110.002717.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"317_CR21","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1111\/j.1365-2125.1979.tb00449.x","volume":"8","author":"DD Breimer","year":"1979","unstructured":"Breimer DD. Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics. Br J Clin Pharmacol. 1979;8(1):7S\u201313S. https:\/\/doi.org\/10.1111\/j.1365-2125.1979.tb00449.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"317_CR22","first-page":"170","volume":"31","author":"M Seppala","year":"1993","unstructured":"Seppala M, Alihanka J, Himberg JJ, Kanto J, Rajala T, Sourander L. Midazolam and flunitrazepam: pharmacokinetics and effects on night time respiration and body movements in the elderly. Int J Clin Pharmacol Ther Toxicol. 1993;31(4):170\u20136.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"4","key":"317_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Schuttler","year":"2020","unstructured":"Schuttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132(4):636\u201351. https:\/\/doi.org\/10.1097\/ALN.0000000000003103.","journal-title":"Anesthesiology"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-020-00317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:14:31Z","timestamp":1628118871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-020-00317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1007\/s40268-020-00317-0","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"5 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was sponsored by PAION UK Ltd (Cambridge, UK).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Marija Pesic, Thomas St\u00f6hr, Keith Borkett, Martin Donsbach, Van-Anh Dao, and Frank Schippers, as current or former employees of PAION, may own stocks or stock options of PAION. Lynn Webster is an employee at PRA Early Development Services, the CRO that conducted these two clinical trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Both trials were carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). Trial 1 protocol was approved by the Midlands Independent Review Board and trial 2 protocol was approved by the Schulman Independent Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Participants signed informed consent regarding publishing their data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analysed during the current study are not publicly available because of confidentiality restraints but are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}